178
Participants
Start Date
April 15, 2021
Primary Completion Date
February 29, 2024
Study Completion Date
February 29, 2024
HMPL-689
All patients are to receive monotherapy of HMPL-689 30 mg QD continuously in 28-day treatment cycles.
Shanxi Bethune Hospital, Taiyuan
Beijing Chao-yang Hospital, Capital Medical University, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Peking University Third Hospital, Beijing
The First Hospital of Jilin University, Changchun
Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
Fudan University Shanghai Cancer Center, Shanghai
The First People's Hospital of Nantong, Nantong
The Second Hospital of Anhui Medical University, Hefei
The affiliated hospital of Qingdao University, Qingdao
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
The First Affiliated Hospital of Nanchang University, Nanchang
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Chongqing University Cancer Hospital, Chongqing
Hunan Cancer Hospital, Changsha
Puyang Oilfield General Hospital, Puyang
The Central Hospital of YongZhou, Yongzhou
Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
People's Hospital of Wuhan University, Wuhan
Henan Cancer Hospital, Zhengzhou
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Sun Yat-sen University Cancer Center, Guangzhou
Nanfang Hospital, Southern Medical University, Guangzhou
Cancer Hospital of Shantou University Medical College, Shantou
Guangxi Medical University Affiliated Tumor Hospital, Nanning
Hainan General Hospital, Haikou
West China Hospital Sichuan University, Chengdu
Affiliated Hospital of North Sichuan Medical College, Nanchong
Cancer Hospital Affiliated to Xinjiang Medical University, Ürümqi
Beijing GoBroad Boren Hospital, Beijing
Beijing Tongren Hospital, Capital Medical University, Beijing
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai
Affiliated Hospital of Chengde Medical University, Chengde
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Xingtai People's Hospital, Xingtai
The First Affiliated Hospital of Harbin Medical University, Harbin
The First Hospital of Harbin, Harbin
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
The Second Xiangya Hospital of Central South University, Changsha
The Second People's Hospital of Huaihua, Huaihua
The Second Affiliated Hospital of Suzhou University, Suzhou
The First Affiliated Hospital of Gannan Medical University, Gannan
Ganzhou People's Hospital, Ganzhou
Jiangxi Provincial Cancer Hospital, Nanchang
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
Shengjing Hospital of China Medical University, Shengyang
Affiliated Hospital of Binzhou Medical University, Binzhou
Jinan Central Hospital, Jinan
Qilu Hospital of Shandong University, Jinan
Shanghai East Hospital, Tongji University School of Medicine, Shanghai
The First Hospital of Shanxi Medical University, Taiyuan
First Affiliated Hospital of Kunming Medical University, Kunming
Yunnan Cancer Hospital, Kunming
Hutchison Medipharma Limited
INDUSTRY